BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15677623)

  • 1. Chemotherapy options and new advances in malignant pleural mesothelioma.
    Steele JP; Klabatsa A
    Ann Oncol; 2005 Mar; 16(3):345-51. PubMed ID: 15677623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel combinations using pemetrexed in malignant mesothelioma.
    Gadgeel SM; Pass HI
    Clin Lung Cancer; 2004 Apr; 5 Suppl 2():S61-6. PubMed ID: 15117427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.
    Ellis P; Davies AM; Evans WK; Haynes AE; Lloyd NS;
    J Thorac Oncol; 2006 Jul; 1(6):591-601. PubMed ID: 17409924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.
    Toyokawa G; Takenoyama M; Hirai F; Toyozawa R; Inamasu E; Kojo M; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Shimokawa M; Seto T; Ichinose Y
    Int J Clin Oncol; 2014 Aug; 19(4):601-6. PubMed ID: 24158772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
    de Perrot M; Feld R; Cho BC; Bezjak A; Anraku M; Burkes R; Roberts H; Tsao MS; Leighl N; Keshavjee S; Johnston MR
    J Clin Oncol; 2009 Mar; 27(9):1413-8. PubMed ID: 19224855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic chemotherapy in the management of malignant peritoneal mesothelioma.
    Garcia-Carbonero R; Paz-Ares L
    Eur J Surg Oncol; 2006 Aug; 32(6):676-81. PubMed ID: 16616827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.
    Zucali PA; Ceresoli GL; Garassino I; De Vincenzo F; Cavina R; Campagnoli E; Cappuzzo F; Salamina S; Soto Parra HJ; Santoro A
    Cancer; 2008 Apr; 112(7):1555-61. PubMed ID: 18286536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant pleural mesothelioma].
    Nishiwaki Y
    Gan To Kagaku Ryoho; 2003 May; 30(5):589-94. PubMed ID: 12795087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of malignant pleural mesothelioma: have we made any progress?].
    Reck M; Heigener DF; Gatzemeier U
    Zentralbl Chir; 2008 Jun; 133(3):238-42. PubMed ID: 18563688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy management of malignant pleural mesothelioma: a phase II study comparing two popular chemotherapy regimens.
    Habib EE; Fahmy ES
    Clin Transl Oncol; 2013 Nov; 15(11):965-8. PubMed ID: 23408040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging role of antifolates in the treatment of malignant pleural mesothelioma.
    Fizazi K; John WJ; Vogelzang NJ
    Semin Oncol; 2002 Feb; 29(1):77-81. PubMed ID: 11836672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma.
    Woods B; Paracha N; Scott DA; Thatcher N
    Lung Cancer; 2012 Feb; 75(2):261-7. PubMed ID: 21937141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging insights into the biology and therapy of malignant mesothelioma.
    Vogelzang NJ
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):35-42. PubMed ID: 12571809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of the frontline platinum-based combination chemotherapy in malignant peritoneal mesothelioma.
    Kim ST; Park JY; Lee J; Park JO; Park YS; Lim HY; Kang WK; Park SH
    Jpn J Clin Oncol; 2010 Nov; 40(11):1031-6. PubMed ID: 20534685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusually large pleural mesothelioma with an outstanding clinical response and long lasting survival: a case report and literature review.
    Zilembo N; Vitali M; Pietrantonio F; Platania M; Del Vecchio M; Bajetta E
    Tumori; 2010; 96(6):1031-4. PubMed ID: 21388071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cisplatin plus pemetrexed and cisplatin plus gemcitabine for the treatment of malignant pleural mesothelioma in Japanese patients.
    Shukuya T; Takahashi T; Imai H; Tokito T; Ono A; Akamatsu H; Taira T; Kenmotsu H; Naito T; Murakami H; Endo M; Yamamoto N
    Respir Investig; 2014 Mar; 52(2):101-6. PubMed ID: 24636265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standard therapy for the treatment of malignant pleural mesothelioma.
    Vogelzang NJ
    Lung Cancer; 2005 Oct; 50 Suppl 1():S23-4. PubMed ID: 16291429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemetrexed-cisplatin combination in mesothelioma.
    Reck M; Gatzemeier U
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):231-7. PubMed ID: 15877521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care?
    Rusch VW
    J Clin Oncol; 2003 Jul; 21(14):2629-30. PubMed ID: 12860935
    [No Abstract]   [Full Text] [Related]  

  • 20. Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience.
    Pasello G; Nicotra S; Marulli G; Rea F; Bonanno L; Carli P; Magro C; Jirillo A; Favaretto A
    Lung Cancer; 2011 Sep; 73(3):351-5. PubMed ID: 21296448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.